Quantcast
Googles Next Project Discover What The Perfectly Healthy

Google's Next Project: Discover What The Perfectly Healthy Person Looks Like

redOrbit Staff & Wire Reports - Your Universe Online Having already waded knee-deep into the world of driverless cars, optical head-mounted displays and other wearable technology, Google is reportedly poised to tackle its biggest challenge...

Latest Biomarker Stories

2014-07-30 08:32:03

Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million Series C Preferred Stock financing. The financing included new investors...

2014-07-30 08:31:59

SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as chairman of Epic's board of directors. Mr. Lucier was previously chairman and CEO of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic's board of directors to provide expertise as Epic commercializes its circulating...

2014-07-29 23:02:07

A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and the development of Alzheimer’s disease interventions, according to an article published July 29, 2014. Pomona, California (PRWEB) July 29, 2014 A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk...

2014-07-28 04:21:34

HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- - Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA for non-small cell lung cancer patients - New blood test will build on QIAGEN's FDA-approved therascreen EGFR test and is planned to run on Rotor-Gene Q, member of the QIAsymphony family of automated instruments -...

2014-07-25 04:21:20

PARIS, July 25, 2014 /PRNewswire/ -- New publication in Nature by international research team including Enterome scientific founder Professor Dusko Ehrlich ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, and with a strong focus on liver diseases, highlights the advanced online publication in Nature (ref. 1) of a research paper describing...

2014-07-24 23:09:34

GIA announces the release of a comprehensive global report on Molecular Diagnostics markets. Global market for Molecular Diagnostics is projected to reach US$10.7 billion by 2020, driven by aging population, increasing prevalence of chronic and life-threatening diseases, growing need for better disease diagnostics, and advancements in proteomics and genomics. San Jose, California (PRWEB) July 24, 2014 Follow us on LinkedIn – Molecular diagnosis represents a rapidly expanding sector in...

2014-07-24 08:34:02

Over 90% of respondents to a post-clinical briefing survey agree that sub-epidermal moisture (SEM) is a meaningful biomarker for the early indication of pressure-induced tissue damage LOS ANGELES, July 24, 2014 /PRNewswire/ -- Bruin Biometrics (BBI), a pioneer in biometric-sensor based medical devices, announced today that after two weeks of clinical briefings to over 200 pressure ulcer experts throughout the European Union, it gained substantial concurrence on both the clinical...

2014-07-24 08:31:45

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today the appointment of Adam Simpson as president and chief operating officer (COO). Cypher Genomics provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting. "Cypher's technology has the potential to play a transformative role to improve healthcare by enhancing diagnostic accuracy, optimizing...

2014-07-24 08:31:43

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing technology, the NextBio platform for...

2014-07-15 08:28:42

Highly sensitive and easy-to-use technology validated in over 100 papers in three years; probe library exceeds 4000 HAYWARD, California, July 15, 2014 /PRNewswire/ -- Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, announces that its RNAscope(R) RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related